# Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

> **NCT01574703** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 4595 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** placebo
- **DRUG:** varenicline tartrate
- **DRUG:** bupropion hydrochloride
- **DRUG:** Nicotine Replacement Therapy Patch

## Key facts

- **NCT ID:** NCT01574703
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 4595 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01574703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01574703, "Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01574703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*